Author:
Zhang Yunyan,Liu Wei-Qiao,Hosseinpour Zahra,Pike G. Bruce,Cerchiaro Graziela,Greenfield Jamie,Yong V. Wee,Metz Luanne M.
Funder
Hotchkiss Brain Institute
Alberta Innovates
Reference38 articles.
1. Mapping multiple sclerosis around the world - key epidemiology findings;Atlas of MS,2020
2. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study;Brown;Lancet Neurol.,2021
3. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial;Cadavid;Lancet Neurol.,2019
4. MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease;Cortese;Front. Neurol.,2021
5. The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis;Diebold;Ther. Adv. Neurol. Disord.,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献